Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Xconomy: Tp Therapeutics Names New Ceo, Gets $80M More For Cancer Drug Push
Venture Capital

Xconomy: Tp Therapeutics Names New Ceo, Gets $80M More For Cancer Drug Push

by xconomy.com posted 1year ago 60 views
Five-year-old biotech TP Therapeutics has raised an $80 million mezzanine financing round and promoted its chief medical officer, Athena Countouriotis, to CEO. The San Diego-based biotech, which is developing targeted cancer drugs for people whose tumors resist other precision therapies, announced the changes Friday. TP Therapeutics is developing a drug called repotrectinib that targets a […]